Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/30/2025

Mood Stabilization in Bipolar I Disorder

Comparative Efficacy for Mood Stabilization

  • The American Academy of Child and Adolescent Psychiatry recommends lithium for patients 12 years and older for both acute mania and maintenance therapy in bipolar disorder 1
  • The American Academy of Child and Adolescent Psychiatry recommends valproate for acute mania in adults, though it is commonly used in clinical practice for maintenance therapy as well 2
  • A randomized controlled trial found no significant differences in relapse rates between lithium and valproate when used as maintenance monotherapy in children and adolescents with bipolar disorder 3, 4

Specific Clinical Considerations

Manic Episodes

  • Both lithium and valproate are effective first-line treatments for acute mania, according to the American Academy of Child and Adolescent Psychiatry 2, 1
  • Combination therapy with atypical antipsychotics may provide additional benefit for both medications, as suggested by the American Academy of Child and Adolescent Psychiatry 3
  • Valproate plus quetiapine was found to work better than valproate alone for adolescent mania in a double-blind controlled trial, according to the American Academy of Child and Adolescent Psychiatry 3

Depressive Episodes and Anxiety

  • Limited direct comparative data exists specifically addressing anxiety management between the two medications, according to the American Academy of Child and Adolescent Psychiatry 2
  • A history of treatment response in parents may predict response in offspring, as suggested by the American Academy of Child and Adolescent Psychiatry 2

Maintenance Treatment

  • Both medications are recommended for maintenance treatment of bipolar disorder for at least 12-24 months after stabilization, according to the American Academy of Child and Adolescent Psychiatry 4, 1
  • Lithium withdrawal has been associated with increased risk of relapse, especially within 6 months of discontinuation, as reported by the American Academy of Child and Adolescent Psychiatry 1

Monitoring Requirements and Safety Considerations

Lithium

  • Requires baseline laboratory assessment including complete blood cell counts, thyroid function tests, urinalysis, blood urea nitrogen, creatinine, and serum calcium levels, as recommended by the American Academy of Child and Adolescent Psychiatry 1
  • Regular monitoring of lithium levels, renal and thyroid function every 3-6 months is necessary, according to the American Academy of Child and Adolescent Psychiatry 1
  • Has a narrow therapeutic window requiring close clinical monitoring, as reported by the American Academy of Child and Adolescent Psychiatry 1

Valproate

  • Requires baseline liver function tests, complete blood cell counts, and pregnancy tests, as recommended by the American Academy of Child and Adolescent Psychiatry 4
  • Serum drug levels, hepatic and hematological indices should be monitored periodically (every 3-6 months), according to the American Academy of Child and Adolescent Psychiatry 4
  • Associated with concerns regarding development of polycystic ovary disease in females, as reported by the American Academy of Child and Adolescent Psychiatry 4

REFERENCES

1

Lithium Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. [LINK]

Journal of the American Academy of Child and Adolescent Psychiatry, 2007

3

practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. [LINK]

Journal of the American Academy of Child and Adolescent Psychiatry, 2007

4

practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. [LINK]

Journal of the American Academy of Child and Adolescent Psychiatry, 2007